JOINT FILING AGREEMENTJoint Filing Agreement • August 20th, 2021 • Lind Global Fund II LP • Pharmaceutical preparations
Contract Type FiledAugust 20th, 2021 Company IndustryThe undersigned hereby agree that a single Schedule 13G (or any amendment thereto) relating to the Common Stock, par value $0.01 per share, of EyeGate Pharmaceuticals, Inc. shall be filed on behalf of each of the undersigned and that this Agreement shall be filed as an exhibit to such Schedule 13G.
JOINT FILING AGREEMENTJoint Filing Agreement • February 13th, 2024 • Lind Global Fund II LP • Semiconductors & related devices
Contract Type FiledFebruary 13th, 2024 Company IndustryThe undersigned hereby agree that a single Schedule 13G (or any amendment thereto) relating to the Common Shares, par value $0.0001, of WiSA Technologies, Inc. shall be filed on behalf of each of the undersigned and that this Agreement shall be filed as an exhibit to such Schedule 13G.
JOINT FILING AGREEMENTJoint Filing Agreement • February 13th, 2024 • Lind Global Fund II LP • Biological products, (no disgnostic substances)
Contract Type FiledFebruary 13th, 2024 Company IndustryThe undersigned hereby agree that a single Schedule 13G (or any amendment thereto) relating to the Common Stock, par value $0.001 per share, of Windtree Therapeutics, Inc. shall be filed on behalf of each of the undersigned and that this Agreement shall be filed as an exhibit to such Schedule 13G.
JOINT FILING AGREEMENTJoint Filing Agreement • August 7th, 2023 • Lind Global Fund II LP • Pharmaceutical preparations
Contract Type FiledAugust 7th, 2023 Company IndustryThe undersigned hereby agree that a single Schedule 13G (or any amendment thereto) relating to the Common Stock, par value $0.001 per share, of ABVC BioPharma, Inc. shall be filed on behalf of each of the undersigned and that this Agreement shall be filed as an exhibit to such Schedule 13G.
JOINT FILING APPLICATIONJoint Filing Application • February 13th, 2023 • Lind Global Fund II LP • Biological products, (no disgnostic substances)
Contract Type FiledFebruary 13th, 2023 Company IndustryThe undersigned hereby agree that a single Schedule 13G (or any amendment thereto) relating to the Common Stock, par value $0.01 per share, of Palisade Bio, Inc. shall be filed on behalf of each of the undersigned and that this Agreement shall be filed as an exhibit to such Schedule 13G.
JOINT FILING AGREEMENTJoint Filing Agreement • February 13th, 2024 • Lind Global Fund II LP • Prepared fresh or frozen fish & seafoods
Contract Type FiledFebruary 13th, 2024 Company IndustryThe undersigned hereby agree that a single Schedule 13G (or any amendment thereto) relating to the Common Stock, par value $0.0001 per share, of Blue Star Foods Corp. shall be filed on behalf of each of the undersigned and that this Agreement shall be filed as an exhibit to such Schedule 13G.
JOINT FILING AGREEMENTJoint Filing Agreement • February 21st, 2023 • Lind Global Fund II LP • Services-advertising
Contract Type FiledFebruary 21st, 2023 Company IndustryThe undersigned hereby agree that a single Schedule 13G (or any amendment thereto) relating to the Common Stock, par value $0.0001 per share, of Mobiquity Technologies, Inc. shall be filed on behalf of each of the undersigned and that this Agreement shall be filed as an exhibit to such Schedule 13G.
JOINT FILING AGREEMENTJoint Filing Agreement • December 9th, 2022 • Lind Global Fund II LP • Semiconductors & related devices
Contract Type FiledDecember 9th, 2022 Company IndustryThe undersigned hereby agree that a single Schedule 13G (or any amendment thereto) relating to the Common Shares, par value $0.0001, of WiSA Technologies, Inc. shall be filed on behalf of each of the undersigned and that this Agreement shall be filed as an exhibit to such Schedule 13G.
JOINT FILING AGREEMENTJoint Filing Agreement • February 13th, 2024 • Lind Global Fund II LP • Cutlery, handtools & general hardware
Contract Type FiledFebruary 13th, 2024 Company IndustryThe undersigned hereby agree that a single Schedule 13G (or any amendment thereto) relating to the Common Stock, par value $0.0001 per share, of ToughBuilt Industries, Inc. be filed on behalf of each of the undersigned and that this Agreement shall be filed as an exhibit to such Schedule 13G.
JOINT FILING AGREEMENTJoint Filing Agreement • April 17th, 2023 • Lind Global Fund II LP • Pharmaceutical preparations
Contract Type FiledApril 17th, 2023 Company IndustryThe undersigned hereby agree that a single Schedule 13G (or any amendment thereto) relating to the Common Stock, par value $0.0001 per share, OncoSec Medical Incorporated, shall be filed on behalf of each of the undersigned and that this Agreement shall be filed as an exhibit to such Schedule 13G.
JOINT FILING AGREEMENTJoint Filing Agreement • February 14th, 2023 • Lind Global Fund II LP • Surgical & medical instruments & apparatus
Contract Type FiledFebruary 14th, 2023 Company IndustryThe undersigned hereby agree that a single Schedule 13G (or any amendment thereto) relating to the Common Stock, par value $0.001 per share, of SINTX Technologies, Inc. shall be filed on behalf of each of the undersigned and that this Agreement shall be filed as an exhibit to such Schedule 13G.
JOINT FILING AGREEMENTJoint Filing Agreement • February 13th, 2023 • Lind Global Fund II LP • Agricultural services
Contract Type FiledFebruary 13th, 2023 Company IndustryThe undersigned hereby agree that a single Schedule 13G (or any amendment thereto) relating to the Common Stock, par value $0.00001 per share, of CEA Industries Inc., shall be filed on behalf of each of the undersigned and that this Agreement shall be filed as an exhibit to such Schedule 13G.
JOINT FILING AGREEMENTJoint Filing Agreement • July 3rd, 2023 • Lind Global Fund II LP • Misc industrial & commercial machinery & equipment
Contract Type FiledJuly 3rd, 2023 Company IndustryThe undersigned hereby agree that a single Schedule 13G (or any amendment thereto) relating to the Ordinary Shares, par value $0.0001 per share, of SMX (Security Matters) Public Limited Company, shall be filed on behalf of each of the undersigned and that this Agreement shall be filed as an exhibit to such Schedule 13G.
JOINT FILING AGREEMENTJoint Filing Agreement • March 10th, 2023 • Lind Global Fund II LP • Surgical & medical instruments & apparatus
Contract Type FiledMarch 10th, 2023 Company IndustryThe undersigned hereby agree that a single Schedule 13G (or any amendment thereto) relating to the Common Stock, par value $0.01 per share, of Intelligent Bio Solutions Inc. shall be filed on behalf of each of the undersigned and that this Agreement shall be filed as an exhibit to such Schedule 13G.
JOINT FILING AGREEMENTJoint Filing Agreement • June 30th, 2023 • Lind Global Fund II LP • Cutlery, handtools & general hardware
Contract Type FiledJune 30th, 2023 Company IndustryThe undersigned hereby agree that a single Schedule 13G (or any amendment thereto) relating to the Common Stock, par value $0.0001 per share, of ToughBuilt Industries, Inc., shall be filed on behalf of each of the undersigned and that this Agreement shall be filed as an exhibit to such Schedule 13G.
JOINT FILING AGREEMENTJoint Filing Agreement • February 13th, 2024 • Lind Global Fund II LP • Radiotelephone communications
Contract Type FiledFebruary 13th, 2024 Company IndustryThe undersigned hereby agree that a single Schedule 13G (or any amendment thereto) relating to the Common Shares, no par value, of Siyata Mobile Inc. shall be filed on behalf of each of the undersigned and that this Agreement shall be filed as an exhibit to such Schedule 13G.
JOINT FILING AGREEMENTJoint Filing Agreement • October 19th, 2021 • Lind Global Fund II LP • Oil & gas field machinery & equipment
Contract Type FiledOctober 19th, 2021 Company IndustryThe undersigned hereby agree that a single Schedule 13G (or any amendment thereto) relating to the Common Stock, $0.001 par value, of Superior Drilling Products, Inc. shall be filed on behalf of each of the undersigned and that this Agreement shall be filed as an exhibit to such Schedule 13G.
JOINT FILING AGREEMENTJoint Filing Agreement • February 13th, 2024 • Lind Global Fund II LP • Pharmaceutical preparations
Contract Type FiledFebruary 13th, 2024 Company IndustryThe undersigned hereby agree that a single Schedule 13G (or any amendment thereto) relating to the Common Stock, par value $0.0001 per share, of Agile Therapeutics, Inc. shall be filed on behalf of each of the undersigned and that this Agreement shall be filed as an exhibit to such Schedule 13G.
JOINT FILING APPLICATIONJoint Filing Application • February 13th, 2023 • Lind Global Fund II LP • Pharmaceutical preparations
Contract Type FiledFebruary 13th, 2023 Company IndustryThe undersigned hereby agree that a single Schedule 13G (or any amendment thereto) relating to the Common Stock, par value $0.0001 per share, of Agile Therapeutics, Inc. shall be filed on behalf of each of the undersigned and that this Agreement shall be filed as an exhibit to such Schedule 13G.
JOINT FILING AGREEMENTJoint Filing Agreement • November 9th, 2023 • Lind Global Fund II LP • Gold and silver ores
Contract Type FiledNovember 9th, 2023 Company IndustryThe undersigned hereby agree that a single Schedule 13G (or any amendment thereto) relating to the Common Stock, par value $0.01 per share, of Golden Minerals Company shall be filed on behalf of each of the undersigned and that this Agreement shall be filed as an exhibit to such Schedule 13G.
JOINT FILING APPLICATIONJoint Filing Application • February 13th, 2023 • Lind Global Fund II LP • Electromedical & electrotherapeutic apparatus
Contract Type FiledFebruary 13th, 2023 Company IndustryThe undersigned hereby agree that a single Schedule 13G (or any amendment thereto) relating to the Common Stock, par value $0.0001 per share, of Nuwellis, Inc. shall be filed on behalf of each of the undersigned and that this Agreement shall be filed as an exhibit to such Schedule 13G.
JOINT FILING AGREEMENTJoint Filing Agreement • March 3rd, 2023 • Lind Global Fund II LP • Surgical & medical instruments & apparatus
Contract Type FiledMarch 3rd, 2023 Company IndustryThe undersigned hereby agree that a single Schedule 13G (or any amendment thereto) relating to the American Depository Shares of Quoin Pharmaceuticals Ltd. shall be filed on behalf of each of the undersigned and that this Agreement shall be filed as an exhibit to such Schedule 13G.
JOINT FILING AGREEMENTJoint Filing Agreement • June 2nd, 2023 • Lind Global Fund II LP • Services-medical laboratories
Contract Type FiledJune 2nd, 2023 Company IndustryThe undersigned hereby agree that a single Schedule 13G (or any amendment thereto) relating to the Common Stock, par value $0.0001 per share, of Biocept, Inc. shall be filed on behalf of each of the undersigned and that this Agreement shall be filed as an exhibit to such Schedule 13G.
JOINT APPLICATION FILINGJoint Application Filing • February 13th, 2023 • Lind Global Fund II LP • Deep sea foreign transportation of freight
Contract Type FiledFebruary 13th, 2023 Company IndustryThe undersigned hereby agree that a single Schedule 13G (or any amendment thereto) relating to the Common Shares, $0.01 par value per share, of Performance Shipping Inc., shall be filed on behalf of each of the undersigned and that this Agreement shall be filed as an exhibit to such Schedule 13G.
JOINT FILING AGREEMENTJoint Filing Agreement • July 13th, 2022 • Lind Global Fund II LP • Services-help supply services
Contract Type FiledJuly 13th, 2022 Company IndustryThe undersigned hereby agree that a single Schedule 13G (or any amendment thereto) relating to the Common Stock, par value $0.00001 per share, of Staffing 360 Solutions, Inc. shall be filed on behalf of each of the undersigned and that this Agreement shall be filed as an exhibit to such Schedule 13G.
JOINT FILING AGREEMENTJoint Filing Agreement • February 21st, 2023 • Lind Global Fund II LP • Pharmaceutical preparations
Contract Type FiledFebruary 21st, 2023 Company IndustryThe undersigned hereby agree that a single Schedule 13G (or any amendment thereto) relating to the Common Stock, par value $0.001 per share, of Revelation Biosciences, Inc. shall be filed on behalf of each of the undersigned and that this Agreement shall be filed as an exhibit to such Schedule 13G.
JOINT FILING AGREEMENTJoint Filing Agreement • March 19th, 2024 • Lind Global Fund II LP • Pharmaceutical preparations
Contract Type FiledMarch 19th, 2024 Company IndustryThe undersigned hereby agree that a single Schedule 13G (or any amendment thereto) relating to the Ordinary Shares, par value $0.01 per share, of ASLAN Pharmaceuticals Limited shall be filed on behalf of each of the undersigned and that this Agreement shall be filed as an exhibit to such Schedule 13G.
JOINT FILING AGREEMENTJoint Filing Agreement • January 4th, 2024 • Lind Global Fund II LP • Pharmaceutical preparations
Contract Type FiledJanuary 4th, 2024 Company IndustryThe undersigned hereby agree that a single Schedule 13G (or any amendment thereto) relating to the Common Stock, par value $0.001 per share, of Cyclacel Pharmaceuticals, Inc. shall be filed on behalf of each of the undersigned and that this Agreement shall be filed as an exhibit to such Schedule 13G.
JOINT FILING AGREEMENTJoint Filing Agreement • February 23rd, 2022 • Lind Global Fund II LP • Agricultural services
Contract Type FiledFebruary 23rd, 2022 Company IndustryThe undersigned hereby agree that a single Schedule 13G (or any amendment thereto) relating to the Common Stock, par value $0.00001 per share, of CEA Industries Inc. shall be filed on behalf of each of the undersigned and that this Agreement shall be filed as an exhibit to such Schedule 13G.
JOINT FILING AGREEMENTJoint Filing Agreement • February 21st, 2024 • Lind Global Fund II LP • Dental equipment & supplies
Contract Type FiledFebruary 21st, 2024 Company IndustryThe undersigned hereby agree that a single Schedule 13G (or any amendment thereto) relating to the Common Stock, par value $0.001 per share, of BIOLASE, INC. shall be filed on behalf of each of the undersigned and that this Agreement shall be filed as an exhibit to such Schedule 13G.
JOINT FILING AGREEMENTJoint Filing Agreement • February 13th, 2024 • Lind Global Fund II LP • Pharmaceutical preparations
Contract Type FiledFebruary 13th, 2024 Company IndustryThe undersigned hereby agree that a single Schedule 13G (or any amendment thereto) relating to the Common Stock, par value $0.0001 per share, of TransCode Therapeutics, Inc. shall be filed on behalf of each of the undersigned and that this Agreement shall be filed as an exhibit to such Schedule 13G.
JOINT FILING AGREEMENTJoint Filing Agreement • December 5th, 2022 • Lind Global Fund II LP • Services-computer rental & leasing
Contract Type FiledDecember 5th, 2022 Company IndustryThe undersigned hereby agree that a single Schedule 13G (or any amendment thereto) relating to the Common Shares, no par value, of Bragg Gaming Group Inc. shall be filed on behalf of each of the undersigned and that this Agreement shall be filed as an exhibit to such Schedule 13G.
JOINT FILING AGREEMENTJoint Filing Agreement • February 13th, 2024 • Lind Global Fund II LP • Gold and silver ores
Contract Type FiledFebruary 13th, 2024 Company IndustryThe undersigned hereby agree that a single Schedule 13G (or any amendment thereto) relating to the Common Stock, par value $0.01 per share, of Golden Minerals Company shall be filed on behalf of each of the undersigned and that this Agreement shall be filed as an exhibit to such Schedule 13G.
JOINT FILING AGREEMENTJoint Filing Agreement • February 13th, 2024 • Lind Global Fund II LP • Services-computer programming, data processing, etc.
Contract Type FiledFebruary 13th, 2024 Company IndustryThe undersigned hereby agree that a single Schedule 13G (or any amendment thereto) relating to the Common Stock, par value $0.001 per share, of Grom Social Enterprises, Inc. shall be filed on behalf of each of the undersigned and that this Agreement shall be filed as an exhibit to such Schedule 13G.
JOINT FILING AGREEMENTJoint Filing Agreement • January 4th, 2024 • Lind Global Fund II LP • Finance services
Contract Type FiledJanuary 4th, 2024 Company IndustryThe undersigned hereby agree that a single Schedule 13G (or any amendment thereto) relating to the Common Stock, par value $0.001 per share, of Netcapital Inc. shall be filed on behalf of each of the undersigned and that this Agreement shall be filed as an exhibit to such Schedule 13G.